Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154136 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants
A Phase 1 study, sponsored by Arcus Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT05154136 is a Phase 1 study that has completed, run by Arcus Biosciences. The registered enrollment target is 20 participants.
The verdict
NCT05154136, a Phase 1 study, has completed, sponsored by Arcus Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the effect of multiple oral doses of itraconazole, on the pharmacokinetics of etrumadenant when etrumadenant is administered as a single dose in healthy adult participants.
Interventions
- DRUG Itraconazole
- DRUG Etrumadenant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2021-12-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154136
The ClinicalTrials.gov registry entry for NCT05154136 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arcus Biosciences, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Itraconazole is the first listed.
NCT05154136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05154136 about?
NCT05154136 is a clinical study titled "A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants". This study will evaluate the effect of multiple oral doses of itraconazole, on the pharmacokinetics of etrumadenant when etrumadenant is administered as a single dose in healthy adult participants.
What is the current status of trial NCT05154136?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2021-10-20. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT05154136?
The interventions under investigation include: Itraconazole (DRUG), Etrumadenant (DRUG).
Who is sponsoring clinical trial NCT05154136?
This trial is sponsored by Arcus Biosciences, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.